Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.41 |
| ▸ | CCR5 | P51681 | 3/20 | 0.41 |
| ▸ | CCR8 | P51685 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | UNG | P13051 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL730405 | 0.98 | CCR1 (0.42) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL29387096 | 0.98 | CCR1 (0.42) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL30259309 | 0.95 | CCR1 (0.41) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL17057411 | 0.89 | CYP2A6 (0.37) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL23787847 | 0.87 | KDM4E (0.42) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL1508069 | 0.86 | CCR1 (0.65) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL30472762 | 0.86 | KDM4E (0.54) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL29943121 | 0.86 | CCR1 (0.65) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL4541928 | 0.86 | KDM4E (0.54) | CCR1CCR5CCR8ALDH1A1KDM4E | |
| SCHEMBL3721732 | 0.84 | KDM4E (0.44) | CCR1CCR5CCR8ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230087073-A1 | ANTI-CANCER GOLD COMPLEX, PROCESS OF SYNTHESIS AND METHOD OF TREATMENT THEREOF | KING SAUD UNIVERSITY (SA) | 2023-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230087073-A1 | ANTI-CANCER GOLD COMPLEX, PROCESS OF SYNTHESIS AND METHOD OF TREATMENT THEREOF | NDUFAB1, AIFM1, NDUFV2 | CCR1 4860/4885CCR5 4705/4885CCR8 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.